MaxCyte MXCT Business Segments — Goodwill Impairment
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The official record: MaxCyte’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's business segments — goodwill impairment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MaxCyte's business segments — goodwill impairment?
- MaxCyte (MXCT) reported business segments — goodwill impairment of $888.5K in Q4 2025.
- What does business segments — goodwill impairment mean?
- This metric reflects a non-cash charge recorded when the carrying value of goodwill associated with the cell engineering technology segment exceeds its implied fair value. It serves as an indicator that the segment's long-term economic prospects or market value may have declined below initial expectations. Investors monitor this to identify potential risks related to past acquisitions or shifts in the segment's competitive landscape.